BEAM
Price
$16.80
Change
-$0.34 (-1.98%)
Updated
Jun 27 closing price
Capitalization
1.69B
45 days until earnings call
DNLI
Price
$14.10
Change
-$0.39 (-2.69%)
Updated
Jun 27 closing price
Capitalization
2.05B
33 days until earnings call
Interact to see
Advertisement

BEAM vs DNLI

Header iconBEAM vs DNLI Comparison
Open Charts BEAM vs DNLIBanner chart's image
Beam Therapeutics
Price$16.80
Change-$0.34 (-1.98%)
Volume$4.49M
Capitalization1.69B
Denali Therapeutics
Price$14.10
Change-$0.39 (-2.69%)
Volume$4.08M
Capitalization2.05B
BEAM vs DNLI Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. DNLI commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Buy and DNLI is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (BEAM: $16.80 vs. DNLI: $14.10)
Brand notoriety: BEAM and DNLI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 238% vs. DNLI: 276%
Market capitalization -- BEAM: $1.69B vs. DNLI: $2.05B
BEAM [@Biotechnology] is valued at $1.69B. DNLI’s [@Biotechnology] market capitalization is $2.05B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileDNLI’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • DNLI’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 3 TA indicator(s) are bullish while DNLI’s TA Score has 2 bullish TA indicator(s).

  • BEAM’s TA Score: 3 bullish, 5 bearish.
  • DNLI’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than DNLI.

Price Growth

BEAM (@Biotechnology) experienced а +0.18% price change this week, while DNLI (@Biotechnology) price change was +1.51% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 12, 2025.

DNLI is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($2.05B) has a higher market cap than BEAM($1.69B). DNLI (-30.815) and BEAM (-32.258) have similar YTD gains . BEAM has higher annual earnings (EBITDA): -399.03M vs. DNLI (-505.16M). BEAM has more cash in the bank: 1.22B vs. DNLI (818M). DNLI has less debt than BEAM: DNLI (48.6M) vs BEAM (158M). BEAM has higher revenues than DNLI: BEAM (63.6M) vs DNLI (0).
BEAMDNLIBEAM / DNLI
Capitalization1.69B2.05B82%
EBITDA-399.03M-505.16M79%
Gain YTD-32.258-30.815105%
P/E RatioN/AN/A-
Revenue63.6M0-
Total Cash1.22B818M149%
Total Debt158M48.6M325%
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
60
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMDNLI
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
75%
Advances
ODDS (%)
Bullish Trend 11 days ago
78%
Bullish Trend 3 days ago
78%
Declines
ODDS (%)
Bearish Trend 13 days ago
85%
Bearish Trend 9 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
82%
Aroon
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCGYX19.810.24
+1.23%
NYLI PineStone Global Equity Class C
NBFCX34.140.27
+0.80%
Neuberger Berman Focus Trust
RYANX137.441.03
+0.76%
Rydex Nova A
PGELX27.110.06
+0.22%
George Putnam Balanced R5
HBLYX14.85N/A
N/A
Hartford Balanced Income Y

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
-1.98%
CRSP - BEAM
71%
Closely correlated
+1.69%
RXRX - BEAM
64%
Loosely correlated
-6.85%
NTLA - BEAM
63%
Loosely correlated
-0.52%
DNLI - BEAM
61%
Loosely correlated
-2.69%
SYRE - BEAM
59%
Loosely correlated
-4.99%
More

DNLI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNLI has been loosely correlated with BEAM. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if DNLI jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNLI
1D Price
Change %
DNLI100%
-2.69%
BEAM - DNLI
61%
Loosely correlated
-1.98%
NRIX - DNLI
59%
Loosely correlated
+0.17%
RGNX - DNLI
58%
Loosely correlated
-4.11%
ARWR - DNLI
57%
Loosely correlated
+0.06%
ATXS - DNLI
57%
Loosely correlated
+2.39%
More